← All organizations

Parker Research Institute

Academic/Hospital

Also known as: Henrik Gudbergsen | Parker Research Institute

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Nov 1, 2016

Timeline

2010s

Jul 1, 2016
Parker Research Institute— Founded

Drugs by trial phase (1 distinct, 5 trials)

Phase 4 (1 own, 0 via acquisition)

liraglutide

Indications

Studied for

Recent trials (10)

NCT02928614Lead sponsorPhase 4Nov 1, 2016
NCT02928614Sponsor investigatorPhase 4Nov 1, 2016
NCT02928679Lead sponsorPhase 4Nov 1, 2016
NCT02928679Sponsor investigatorPhase 4Nov 1, 2016
NCT02931383Lead sponsorPhase 4Nov 1, 2016
NCT02931383Sponsor investigatorPhase 4Nov 1, 2016
NCT02905864Sponsor investigatorPhase 4Nov 1, 2016
NCT02910570Reponsible party - principal investigatorPhase 4Nov 1, 2016
NCT02910570Lead sponsorPhase 4Nov 1, 2016
NCT02905864Lead sponsorPhase 4Nov 1, 2016

Details

Founded: San Francisco, California, US Jul 1, 2016
Last known activity: Nov 1, 2016